ROSAS-PERALTA, Martin et al. Beyond Mineralocorticoid Receptor Blockade: Aldosterone Synthase Inhibition as a New Therapeutic Frontier in the Cardiovascular–Kidney–Metabolic Era-What is really new?. Annals of Clinical Hypertension, [S. l.], p. 52–64, 2026. DOI: 10.29328/journal.ach.1001047. Disponível em: https://www.clinhypertensionjournal.com/ach/article/view/ach-aid1047. Acesso em: 11 nov. 2026.